pages:
-
A MULTI-CENTER, NONRANDOMIZED PHARMACOKINETIC STUDY OF MAKENA (HYDROXYPROGESTERONE CAPROATE INJECTION, 250 MG/ML) AND ITS METABOLITES IN BLOOD AND URINE OF WOMEN WITH A SINGLETON PREGNANCY AND A PREVIOUS SINGLETON SPONTANEOUS PRETERM DELIVERY
-
A Multi-Center, Open-Label, Parallel-Arm, Randomized, Dose-Ranging Study of ENV515 (travoprost) Intracameral
Implant in Subjects with Bilateral Ocular Hypertension or Early Primary Open-Angle Glaucoma
Research Grant
-
A Multi-center, Open-label, Single-arm Phase 2/3 Trial Evaluating the Safety and Pharmacokinetics of Calaspargase Pegol for Treatment of Adults Aged 22 To >65 Years with Newly-diagnosed Philadelphia-negative ALL
-
A Multi-center, phase 1/2 open label study of Selinexor (KPT-330), Lenalidomide, and Dexamethasone in patients with R/R MM
-
A multi-center, randomized double-blind, three-arm, parallel-group trial to assess the efficacy and safety of NTRA-9620 in infants with short bowel syndrome (SBS) following surgical resection
-
A Multi-center, Randomized, Case-controlled, Ascending-dose Study of Extracorporeal Mesenchymal Stromal Cell Therapy (SBI-101 therapy) in COVID-19 Subjects with Acute Kidney Injury Receiving Renal Replacement Therapy
-
A Multi-Center, Randomized, Double-Blind, 12 Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RO5285119 in Individuals with Autism Spectrum Disorders (ASD)
-
A multi-center, randomized, double-blind, parallel-group, multiple dose, adaptive study assessing the pharmacokinetics, pharmacodynamics, safety and tolerability of TTP399 in adult patients with type 1 diabetes mellitus.
-
A multi-center, randomized, double-blind, placebo controlled, parallel group study to compare cessation versus continuation of long-term mepolizumab treatment in patients with severe eosinophilic asthma (201810)
-
A Multi-Center, Randomized, Double-Blind, Placebo-and Active Comparator-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of BMS-986165 in Subjects with Moderate-to-Severe Plaque Psoriasis
-
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Phae III trial of the FLT3 Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients with FLT3-ITD AML BMT CTN Protocol 1506
-
A Multi-Centre Study in Patients Undergoing Total Knee Replacement with Smith+Nephew Porous Total Knee Arthroplasty (TKA) System
-
A Multi-institutional Randomized Controlled Trial to Determine the Optimal Antibiotic Prophylaxis for Tissue Expander-based Breast Reconstruction
-
A Multi-level, Salon-Based Intervention to Promote Awareness, Accurate Knowledge and Uptake of PrEP Among Black Women Living in the United States South
Research Grant
-
A Multi-omics and Multi-Species Examination of Combined Environmental Stressors of Space Exploration
Research Grant
-
A Multi-Sensor-Fused Intelligent Biomimetic Microrobot
Research Grant
-
A Multi-Sensor-Fused Intelligent Biomimetric Microrobot (REU Supplement)
Research Grant
-
A Multi-State Analysis of the Impact of HIV Exposure Laws - Latino Supplement Proyecto Luz
-
A Multicenter international observational study of the long term safety of Infliximab (RESULTS)
Fellowships, Supported Research, and Other Grants
-
A Multicenter Non-Interventional Study to Obtain Retrospective Data for Subjects Previously Diagnosed with Adenovirus Infection to serve as Matched Historical Controls for Study CMX001-304
Research Grant
-
A Multicenter phase 1/1b open label dose escalation study of ABT-165 a dual variable domain immunoglobin in subject with advanced solid tumors.
-
A Multicenter Phase I/Ib open label dose escalation study of ABBV-399, and antibody drug conjugate, in subjects with advanced solid tumors.
-
A Multicenter randomized open label study in patients with esophageal cancer refractory or intorlerant to combination therapy with fluoropyrimidine
-
A multicenter randomized, controlled trial to compare the efficacy of ex-vivo normothermic machine perfusion with static cold storage in human liver transplantation
-
A multicenter rendomized open label phase 3 trial to compare the efficacy and safety of Lenvatinib versus Sorafenib in first line treatment of subject with unresectable hepatocellular carcinoma.
-
A multicenter retrospective non-interventional follow-up study in patients with sickle cell pain crisis who previously participated in the SUSTAIN trial in the United States
-
A multicenter retrospective observational study to evaluate primary patency of arteriovenous fistulae 6 months post-surgery
Research Grant
-
A Multicenter Retrospective Study of Avance® Nerve Graft Utilization, Evaluations and Outcomes in Peripheral Nerve Injury Repair. (RANGER®)
Research Grant
-
A multicenter study of apheresis collection of peripheral blood mononuclear (PBMC) in patients with CD19 expressing malignancies who could be eligible for a CTL019 clinical research trial
-
A Multicenter Study of Genomic and Psychological Factors Affecting Postoperative and Chronic Pain in Children Undergoing Invasive (Spine) Surgery
Research Grant
pages: